FDA Investigator Jill Mielziner
Jill Mielziner has conducted inspections on 14 sites in 1 countries as of 26 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
26 Feb 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jill Mielziner:
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Annemarie Bodnar,
Annet R Rajan,
Antoinette L Ravelli,
Barbara J Maulfair,
Barbara Jwilimczyk Macri,
Brandi L Garbutt,
Brian D Young,
Carol A Perry,
Carol A Robles,
Charlotte P Chang,
Daniel J Grabicki,
Deborah J Parris,
Devon Jenkins,
Dhaval H Patel,
Doreen P Canetti,
Doreen P Gubbay,
Douglas C Kovacs,
Edward O'shaughnessy,
Eric J Cunningham,
Eric Rothschild,
Helen Verdel,
Jessica M Monteiro,
Jill M Sooter,
Jo Annc Declement,
Jose M Cayuela,
Josh Renzo N Ramilo,
Judith A Jones,
Justin A Boyd,
Justine Tomasso,
Karen A Spencer,
Karen E D'orazio,
Karishma G Gopaul,
Kelli F Dobilas,
Kelly I Anderson,
Kerry A Kurdilla,
Kris K Moore,
Kristy A Zielny,
Larry Johnson,
Lata C Mathew, PhD,
Lawrence R Johnson,
Li Li,
Marjorie D Schultz,
Meredith L Sheridan,
Michael R Klapal,
Michael Rosner,
Nerizza B Guerin,
Paul L Bellamy,
Ray Niles,
Raymond L Cheung,
Raymond Niles,
Regina T Brown,
Remache,
Robin P Mathew,
Samir C Gala,
Schultz,
Teigan M Mule,
Unnee Ranjan,
Valerie C Reed,
Wayne J Meyer,
William J Muszynski,
William W Dotts,
Yvesna C Blaise
Jill Mielziner's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2000 | EIR | Glatt Air Techniques, Inc. - EIR, 2000-03-22 |
July, 2000 | FDA 483 Response | Delaware River & Bay Authority Cape May-Lewes Ferry - Form 483R, 2000-07-17 |
July, 2000 | EIR | Delaware River & Bay Authority Cape May-Lewes Ferry - EIR, 2000-07-12 |
June, 2000 | EIR | Delaware River & Bay Authority Cape May-Lewes Ferry - EIR, 2000-06-14 |
July, 2000 | FDA 483 | Delaware River & Bay Authority Cape May-Lewes Ferry - Form 483, 2000-07-12 |
June, 2000 | FDA 483 | Delaware River & Bay Authority Cape May-Lewes Ferry - Form 483, 2000-06-14 |
August, 2000 | FDA 483 | Delaware River & Bay Authority Cape May-Lewes Ferry - Form 483, 2000-08-10 |
August, 2000 | EIR | Delaware River & Bay Authority Cape May-Lewes Ferry - EIR, 2000-08-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more